Compare Piramal Enterprises with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DR. REDDYS LAB PIRAMAL ENTERPRISES/
DR. REDDYS LAB
 
P/E (TTM) x 88.1 40.9 215.3% View Chart
P/BV x 1.9 4.4 41.9% View Chart
Dividend Yield % 1.3 0.5 232.4%  

Financials

 PIRAMAL ENTERPRISES   DR. REDDYS LAB
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-21
DR. REDDYS LAB
Mar-21
PIRAMAL ENTERPRISES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs2,0085,515 36.4%   
Low Rs8063,028 26.6%   
Sales per share (Unadj.) Rs567.91,145.4 49.6%  
Earnings per share (Unadj.) Rs47.6114.5 41.6%  
Cash flow per share (Unadj.) Rs72.5188.4 38.5%  
Dividends per share (Unadj.) Rs33.0025.00 132.0%  
Avg Dividend yield %2.30.6 400.7%  
Book value per share (Unadj.) Rs1,508.31,053.2 143.2%  
Shares outstanding (eoy) m225.54166.30 135.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.53.7 66.4%   
Avg P/E ratio x29.537.3 79.1%  
P/CF ratio (eoy) x19.422.7 85.6%  
Price / Book Value ratio x0.94.1 23.0%  
Dividend payout %69.321.8 317.2%   
Avg Mkt Cap Rs m317,310710,289 44.7%   
No. of employees `000NANA-   
Total wages/salary Rs m16,50536,299 45.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m128,094190,475 67.2%  
Other income Rs m3,6362,914 124.8%   
Total revenues Rs m131,730193,389 68.1%   
Gross profit Rs m75,23138,699 194.4%  
Depreciation Rs m5,60912,288 45.6%   
Interest Rs m42,085970 4,338.7%   
Profit before tax Rs m31,17328,355 109.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,4299,319 219.2%   
Profit after tax Rs m10,74419,036 56.4%  
Gross profit margin %58.720.3 289.1%  
Effective tax rate %65.532.9 199.4%   
Net profit margin %8.410.0 83.9%  
BALANCE SHEET DATA
Current assets Rs m198,674145,503 136.5%   
Current liabilities Rs m133,47381,038 164.7%   
Net working cap to sales %50.933.8 150.4%  
Current ratio x1.51.8 82.9%  
Inventory Days Days1,68561 2,747.1%  
Debtors Days Days495 4.6%  
Net fixed assets Rs m627,818109,979 570.9%   
Share capital Rs m451832 54.2%   
"Free" reserves Rs m339,729174,319 194.9%   
Net worth Rs m340,180175,151 194.2%   
Long term debt Rs m280,9686,299 4,460.5%   
Total assets Rs m826,493255,482 323.5%  
Interest coverage x1.730.2 5.8%   
Debt to equity ratio x0.80 2,296.6%  
Sales to assets ratio x0.20.7 20.8%   
Return on assets %6.47.8 81.6%  
Return on equity %3.210.9 29.1%  
Return on capital %11.816.2 73.0%  
Exports to sales %051.3 0.0%   
Imports to sales %0.118.1 0.6%   
Exports (fob) Rs mNA97,699 0.0%   
Imports (cif) Rs m13734,420 0.4%   
Fx inflow Rs m1,11697,699 1.1%   
Fx outflow Rs m13734,420 0.4%   
Net fx Rs m97963,279 1.5%   
CASH FLOW
From Operations Rs m36,64535,703 102.6%  
From Investments Rs m-27,723-22,660 122.3%  
From Financial Activity Rs m20,716-298 -6,951.6%  
Net Cashflow Rs m29,70112,858 231.0%  

Share Holding

Indian Promoters % 43.5 26.7 162.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 43.5 49.2 88.5%  
FIIs % 35.3 27.8 127.2%  
ADR/GDR % 0.0 12.1 -  
Free float % 56.5 61.2 92.3%  
Shareholders   153,960 255,720 60.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    



Today's Market

Sensex Trades Marginally Lower as Auto Stocks Witness Selling; Maruti & Eicher Motors Fall 3%(10:30 am)

Asian stock markets are higher today, following the holiday in US markets, as economic recovery optimism returned to the fore.

Related Views on News

PIRAMAL ENTERPRISES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jan 18, 2022 11:05 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS